Evidence map›Paper›PMID 35595199›Full record

Observational studyTravel medicine and infectious disease

Factors associated with the opposition to COVID-19 vaccination certificates: A multi-country observational study from Asia.

Sarin Kc, Dian Faradiba, Manit Sittimart, Wanrudee Isaranuwatchai, Aparna Ananthakrishnan, Chayapat Rachatan, Saudamini Dabak, Asrul Akmal Shafie, Anna Melissa Guerrero, Auliya Suwantika and 9 more

Abstract readObservational Study
In one paragraph

Observational study in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Impact of COVID-19 pandemic on HTAsiaLink network members.International journal of technology assessment in health care · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sarin KcHealth Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.
Dian FaradibaHealth Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.
Manit SittimartHealth Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand. Electronic address: manit.s@hitap.net.
Wanrudee IsaranuwatchaiHealth Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand; Institute of Health Policy, Management and Evaluation, St. Michael's Hospital, University of Toronto, 30 Bond St Toronto, ON M5B 1W8, Canada.
Aparna AnanthakrishnanHealth Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.
Chayapat RachatanHealth Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.
Saudamini DabakHealth Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.
Asrul Akmal ShafieSchool of Pharmaceutical Sciences, 11800, Universiti Sains Malaysia, Pulau Pinang, Malaysia.
Anna Melissa GuerreroHealth Technology Assessment Unit, Department of Health, Manila, 1003, Philippines.
Auliya SuwantikaDepartment of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jl. Raya Bandung-Sumedang Km. 21 Jatinangor, Sumedang, 45363, West Java, Indonesia.
Gagandeep KangDivision of Gastrointestinal Sciences, The Christian Medical College (CMC), IDA Scudder Rd, Vellore, Tamil Nadu, 632004, India.
Jeonghoon AhnDepartment of Health Convergence, Ewha Womans University, 52, Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, Republic of Korea.
Li Yang HsuSaw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS), 12 Science Drive 2, #10-01, 117549, Singapore.
Mayfong MayxayDepartment of Medicine, University of Health Sciences, Samsenthai Road P.O. Box 7444, Vientiane, Laos; Lao-Oxford-Mahosot Hospital-Welcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vietiane, Laos; Centre for Tropical Medicine and Global Health, University of Oxford, United Kingdom.
Natasha HowardSaw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS), 12 Science Drive 2, #10-01, 117549, Singapore; London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK.
Parinda WattanasriDepartment of Disease Control, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand.
Ryota NakamuraHitotsubashi Institute for Advanced Study, Hitotsubashi University, Faculty Building II, 2-1, Naka, Kunitachi, 186 - 8601, Japan.
Tarun K GeorgeDepartment of General Internal Medicine, The Christian Medical College (CMC), IDA Scudder Rd, Vellore, Tamil Nadu, 632004, India.
Yot TeerawattananonHealth Intervention and Technology Assessment Program (HITAP), 6th Floor, 6th Building, Department of Health, Ministry of Public Health, Tiwanon Road, Nonthaburi, 11000, Thailand; Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS), 12 Science Drive 2, #10-01, 117549, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are ongoing calls to harmonise and increase the use of COVID-19 vaccination certificates (CVCs) in Asia. Identifying groups in Asian societies who oppose CVCs and understanding their reasons can help formulate an effective CVCs policy in the region. However, no formal studies have explored this issue in Asia.

methodThe COVID-19 Vaccination Policy Research and Decision-Support Initiative in Asia (CORESIA) was established to address policy questions related to CVCs. An online cross-sectional survey was conducted from June to October 2021 in nine Asian countries. Multivariable logistical regression analyses were performed to identify potential opposers of CVCs.

resultsSix groups were identified as potential opposers of CVCs: (i) unvaccinated (Odd Ratio (OR): 2.01, 95% Confidence Interval (CI): 1.65-2.46); vaccine hesitant and those without access to COVID-19 vaccines; (ii) those not wanting existing NPIs to continue (OR: 2.97, 95% CI: 2.51-3.53); (iii) those with low level of trust in governments (OR: 1.25, 95% CI: 1.02-2.52); (iv) those without travel plans (OR: 1.58, 95% CI: 1.31-1.90); (v) those expecting no financial gains from CVCs (OR: 2.35, 95% CI: 1.98-2.78); and (vi) those disagreeing to use CVCs for employment, education, events, hospitality, and domestic travel.

conclusionsAddressing recurring public health bottlenecks such as vaccine hesitancy and equitable access, adherence to policies, public trust, and changing the narrative from 'societal-benefit' to 'personal-benefit' may be necessary and may help increase wider adoption of CVCs in Asia.

Indexed as

COVID-19COVID-19 VaccinesAsiaCross-Sectional StudiesHumansVaccinationCOVID-19 VaccinesCOVID-19Cross-border travelImmunity certificateRegional collaborationVaccination certificateVaccination passport

Identifiers

PMID35595199
PMCPMC9113761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.